PHD Laboratory

03/13/2026

CHECK OUT THE LINK TO LEARN MORE...

https://varsitybranding.com/2026/03/12/why-senior-living-teams-should-be-talking-about-pgx-testing/

03/11/2026

🎉 Exciting News!

PHD Laboratory has been nominated for the 15th Annual Crowns of Enterprise Awards, which honor outstanding businesses and leaders making a meaningful impact across the Charlotte‑Mecklenburg community.

This milestone event celebrates the legacy of visionary entrepreneurs while recognizing today’s innovators, trailblazers, and community champions who are shaping the future of our city.

We are incredibly proud to see Dr. Troy Veale and the entire PHD Laboratory team acknowledged for excellence in leadership, innovation, and community impact. It is an honor to stand alongside so many remarkable businesses dedicated to making a difference.

Award winners will be announced on May 7. Thank you to everyone who continues to support our mission and the work we do to improve lives through healthcare innovation and strong community partnerships.

02/27/2026

Dr. Troy Veale took center stage at the ARN – Aging Resources Network South February meeting, delivering a powerful and eye‑opening presentation on PGx testing.

His expertise helped members understand how this once‑in‑a‑lifetime genetic test can guide safer, more effective medication choices tailored to your unique chemistry — and it’s covered by Medicare Part B/Advantage.

PHD Laboratory is also grateful to The Haven & The Laurels in The Village at Carolina Place for welcoming us as new hosts and treating everyone to an outstanding breakfast.

02/25/2026

At PHD Laboratory, compliance and accuracy aren’t just promises, they’re the foundation of everything we do. As a CLIA-licensed and COLA-accredited laboratory, we uphold the highest standards to ensure reliable results you can trust.

✅ Precision.
✅ Compliance.
✅ Confidence in every test.

Learn more at info@phdlaboratory.com or explore our services online at www.phdlaboratory.com.

02/25/2026

02/25/2026

PHD Laboratory () was proud to attend the kickoff campaign event for Congresswoman Dr. Alma S. Adams () on February 16 at Middle C Jazz. It was an energizing evening celebrating leadership, community, and the work ahead.

02/24/2026

Medication management in seniors shouldn’t be trial and error.

Adults 65+ are often prescribed 4–5 medications daily,yet most prescriptions are written without insight into how their body will genetically process them.

This is where PGx changes the game.

This week we’re going live to talk about:
✔️ Reducing adverse drug reactions
✔️ Minimizing polypharmacy risks
✔️ Improving medication efficacy
✔️ Strengthening clinical decision-making in senior care

If you work in senior health, long-term care, or support aging populations, this conversation is for you.

Precision medicine isn’t the future. It’s now.

Join us with Dr. Troy Veale, Kiera DesChamps, Michele Cook, CEA, CDP

Thurday, February 26 at 11:30am

HealthcareInnovation

02/13/2026

Team PHD proudly participated in the Health Disparities Symposium held January 23–26, 2026, in Washington, DC, joining national leaders and health equity advocates to advance meaningful dialogue on chronic disease management and strengthen community‑centered care. As part of these conversations, we emphasized the critical role of pharmacogenomic (PGx) testing in addressing long‑standing inequities in treatment outcomes—particularly within minority communities.

PGx testing offers a powerful opportunity to move beyond one‑size‑fits‑all prescribing by identifying how an individual’s genetic makeup influences their response to medications. This is especially important for Black, Hispanic, Asian, Indigenous, and other underserved populations who have historically been underrepresented in clinical research. Many widely used medications were developed and validated in non‑diverse populations, which means their effectiveness and side‑effect risks can differ significantly across ethnic groups.

By integrating PGx testing into routine care, we can help reduce adverse drug reactions, improve treatment precision, and empower patients with knowledge that supports better health decisions. Most importantly, PGx testing serves as a meaningful step toward closing gaps in chronic disease management and ensuring that every community—regardless of background—benefits from the promise of personalized medicine.

Team PHD remains committed to advancing equitable, data‑driven solutions that uplift the communities most impacted by health disparities and bring us closer to a truly inclusive healthcare system.

02/12/2026

Thank you for tuning in to our LinkedIn Live conversation!

We’re excited to keep empowering you with insights on the value of PGx testing and how it can support more personalized, informed healthcare decisions.

Stay connected—there’s so much more to come.

02/10/2026

Love Your Health: PGx in Practice - Clinical Insight & Scientific Oversight

Join PHD Laboratory, Inc. for Week 2 of Love Your Health, our February LinkedIn Live education series focused on pharmacogenomics (PGx) and personalized care.

This session features two of PHD’s key clinical leaders:

Ruben Bonilla Guerrero, MD - Board-certified physician and molecular genetics expert who reviews PGx results and supports clinical interpretation

Jim Mabeka, MD - Chief Scientific Officer, providing scientific oversight and ensuring clinical rigor across PHD’s testing and reporting processes

Together, Dr. Guerrero and Dr. Mabeka will offer an inside look at how PGx testing is reviewed, interpreted, and translated into meaningful, actionable insights for providers, caregivers, and patients.

Who Should Attend

✔ Healthcare providers and clinical teams
✔ Caregivers supporting loved ones with medication management
✔ Community leaders and health advocates
✔ Anyone interested in understanding how genetics influence medication response

Whether you’re new to PGx or looking to deepen your understanding, this session offers valuable insight into how clinical expertise and scientific rigor come together to support better health outcomes.